TB Alliance's Pretomanid Seems OK Heading To Advisory Cmte. As US FDA Showcases Regulatory Flexibility

 
• By Michael Cipriano

The Global Alliance for TB Drug Development is seeking an approval for pretomanid as part of an oral combination regimen for highly resistant tuberculosis. 

Tuberculosis
TB Alliance's Pretomanid Heads To A US FDA Advisory Committee In Good Shape

More from US FDA Performance Tracker

More from Regulatory Trackers